Changing incidence of myeloproliferative neoplasms in Australia, 2003‐2014
Open Access
- 20 January 2019
- journal article
- letter
- Published by Wiley in American Journal of Hematology
- Vol. 94 (4) , E107-E109
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- The delayed diagnosis of myeloproliferative neoplasms is common and results in a high incidence of potentially preventable thrombotic complicationsPathology, 2018
- Real world epidemiology of myeloproliferative neoplasms: a population based study in Korea 2004–2013Annals of Hematology, 2016
- Myeloproliferative neoplasms: trends in incidence, prevalence and survival in NorwayEuropean Journal of Haematology, 2016
- Incidence and patient survival of myeloproliferative neoplasms and myelodysplastic/myeloproliferative neoplasms in the United States, 2001–12British Journal of Haematology, 2016
- A prognostic model to predict survival in 867 World Health Organization–defined essential thrombocythemia at diagnosis: a study by the International Working Group on Myelofibrosis Research and TreatmentBlood, 2012
- Vascular and Neoplastic Risk in a Large Cohort of Patients With Polycythemia VeraJournal of Clinical Oncology, 2005